COMMUNIQUÉS West-GlobeNewswire

Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update

13/11/2018 - 22:05

SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]

Sol-Gel Technologies Reports Third Quarter 2018 Financial Results

13/11/2018 - 22:05

NESS ZIONA, Israel, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update

13/11/2018 - 22:05

- Initiation of Proof-of-Concept Study in Patients with Pulmonary Sarcoidosis Planned for Fourth Quarter of 2018 - - Conference Call Today at 5:00 p.m. ET / 2:00 p.m. PT – SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- [...]

Guardant Health To Report Third Quarter Financial Results on November 19, 2018

13/11/2018 - 22:03

REDWOOD CITY, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter of 2018 after market close on Monday, November 19, 2018. [...]

OpGen Reports third quarter 2018 Financial Results and Provides Business Update

13/11/2018 - 22:02

Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today reported financial and operating results for the three and nine months ended [...]

iCAD Reports Third Quarter 2018 Financial Results

13/11/2018 - 22:01

Company announces board and leadership changes Conference call today at 4:30 p.m. ET NASHUA, N.H., Nov. 13, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology company providing innovative [...]

Imprimis Pharmaceuticals Announces Third Quarter 2018 Results

13/11/2018 - 22:01

SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the third quarter 2018. Third Quarter 2018 and Other Recent Notable Highlights: Revenues increased 66 [...]

Capricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update

13/11/2018 - 22:01

To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first- [...]

CareDx Announces Proposed Public Offering of Common Stock

13/11/2018 - 22:01

BRISBANE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

IntelGenx Closes Private Placement Financing

13/11/2018 - 22:00

SAINT LAURENT, Quebec, Nov. 13, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces the closing of Tilray, Inc.’s strategic investment in IntelGenx by [...]

Synergy CHC Corp. Announces Third Quarter 2018 Results

13/11/2018 - 21:37

Westbrook, Maine, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended September 30th [...]

Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Announcement of the filing of the Joint Terms of Merger

13/11/2018 - 21:36

Press release REGULATED INFORMATION Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG ) - Announcement of the filing of the common draft terms of the [...]

Fusion entre Eckert & Ziegler BEBIG SA (BEBIG) et Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Annonce du dépôt du projet commun de fusion transfrontalière (Projet Commun de Fusion)

13/11/2018 - 21:36

Communiqué de presse Information reglementée Fusion entre Eckert & Ziegler BEBIG SA (BEBIG) et Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Annonce du dépôt du projet commun de fusion [...]

Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer

13/11/2018 - 21:16

Press release Malmö, November 13, 2018 Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer. Per Persson comes directly from the role as Chief [...]

Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program

13/11/2018 - 20:17

COPENHAGEN, Denmark, November 13, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the share buy-back program, which was announced and initiated on November 9, 2018, has now been terminated, as the [...]

Dermatologists Urge Consumers to Treat Acne Early; American Academy of Dermatology

13/11/2018 - 20:00

Treating acne when it first appears can reduce severity, scarring and acne-related anxiety ROSEMONT, Ill., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Acne is the most common skin condition in the United States, affecting up to [...]

Cocrystal Pharma Announces Presentation of Preclinical Characterization Data of CC-42344 at the 6th ISIRV-AVG Conference

13/11/2018 - 17:50

- Company’s novel, broad spectrum influenza antivirals specifically designed to be effective against all significant A strains of the influenza virus - - CC-43244, Company’s lead molecule has demonstrated excellent [...]

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

13/11/2018 - 16:08

ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) reports the following transactions: 1. Details of the person discharging managerial responsibility / person closely associated a) Name Søren Daniel Niegel 2. Reason for the [...]

RadioMedix and Orano Med receive FDA Orphan Drug Designation for AlphaMedix (TM) for the treatment of neuroendocrine tumors

13/11/2018 - 16:00

Houston (TX U.S.), Courbevoie (France), Nov. 13, 2018 (GLOBE NEWSWIRE) -- RadioMedix Inc. (a Texas-based clinical stage biotechnology company) and Orano Med (a nuclear biotechnology company) announced today that the [...]